(UroToday.com) Following Dr. Hussain’s presentation on olaparib in metastatic castration-resistant prostate cancer (mCRPC) in the second prostate cancer session at the 2020 Society of Urologic Oncology (SUO) Annual Virtual Meeting, Dr. Daniel Spratt provided a counterpoint talk entitled, “PROfound-ly Misguided: The Side of the Story They Don’t Want You to Hear.”